Evidence map›Paper›PMID 28455679›Full record

ReviewCurrent obesity reports2017

Weight Loss and Improvement in Comorbidity: Differences at 5%, 10%, 15%, and Over.

Donna H Ryan, Sarah Ryan Yockey

Registry-linked trialAbstract readReview
In one paragraph

Review in Current obesity reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06271200 (Effects of Intensive Lifestyle Interventions), which is not on this map. Cited by 452 papers, 17 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
452citing papers in PubMed, 17 pooled it
19.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06271200 narecruitingnot on this mapstarted 2024, after this paper: background citation

Effects of Intensive Lifestyle Interventions (ILI) on Weight Loss and Cardiometabolic Risks in Obese Adults With Metabolic Syndrome: A Randomized Clinical Trial

TypeinterventionalSponsorNational Health Research Institutes, TaiwanRan2024 to 2027Enrolled200ConditionsMetabolic SyndromeArmsStrategic lifestyle and drug interventions, Control
3 · Its place in the literature

Who cites it

452 citing papers in PubMed, 17 syntheses or guidelines pooled it, 783 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2025
    Guideline
  7. Pooled it
  8. Pharmacotherapy for obesity management in adults: 2025 clinical practice guideline update.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2025
    Guideline
  9. Pooled it
  10. Pooled it
  11. Guideline
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Pooled it
  16. Pooled it
  17. Pooled it
  18. Trial
  19. Weight Loss Responses to Pharmacotherapy in Breast Cancer Survivors: Results from the Adaptive Nutrition and Exercise Weight Loss (A-NEW) Study.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026
    Trial
  20. Trial

392 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Donna H RyanPennington Biomedical Research Center, 6400 Perkins Road, Baton Rouge, LA, 70808, USA. ryandh@pbrc.edu.
Sarah Ryan YockeyDepartment of Obstetrics and Gynecology, LSU School of Medicine, 1542 Tulane Avenue, New Orleans, LA, USA.
Pennington Biomedical Research Center · USTulane University · US

Funding

Tracking & Evaluation CoreU54GM104940 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI JUDD E SHELLITO · 2012 to 2026
$69.1M
NIGMS NIH HHS U54 GM104940
6 · The paper itself

Abstract

purpose of reviewOne begins to see improvement in glycemic measures and triglycerides with small amounts of weight loss, but with greater levels of weight loss there is even greater improvement. In fact, the relationship between weight loss and glycemia is one that is very close. RECENT

findingsThis is fortunate for diabetes prevention; it takes only small amounts of weight loss to prevent progression to type 2 diabetes from impaired glucose tolerance, and after the 10 kg of weight loss, one cannot demonstrate much additional improvement in risk reduction. Modest weight loss (5 to 10%) is also associated with improvement in systolic and diastolic blood pressure and HDL cholesterol. With all these risk factors, more weight loss produces more improvement. Further, for patients with higher BMI levels (>40 kg/m

Indexed as

Weight LossBiomarkersBlood GlucoseBlood PressureComorbidityDiabetes Mellitus, Type 2FemaleHealth StatusHumansHypertensionLipidsNon-alcoholic Fatty Liver DiseaseObesityPolycystic Ovary SyndromePractice Guidelines as TopicQuality of LifeBiomarkersBlood GlucoseLipidsDysglycemiaDyslipidemiaHypertensionInfertilityNon-alcoholic fatty liver diseaseObesityObesity comorbidityObstructive sleep apneaPolycystic ovarian syndromeType 2 diabetesWeight lossWeight loss and comorbidity improvementWeight management

Identifiers

PMID28455679
PMCPMC5497590
OpenAlexW2609075277

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.